Physician profile
Benjamin D Acker
NPI 1104057439
$7,390.37
in general payments reported to CMS, 2019-2025
37 companies · $1,744 in 2025
The $1,744 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $486 · 2021: $279 · 2022: $906 · 2023: $1,686 · 2024: $1,675 · 2025: $1,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,105.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,319.74 | 2019-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $945.44 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $906.48 | 2022-2025 | Inspire |
| Optinose US, INC. | $706.91 | 2019-2025 | |
| Genzyme Corporation | $680.98 | 2019-2025 | |
| Stryker Corporation | $314.48 | 2019-2025 | Clarifix, Hemopore |
| Genentech USA, INC. | $258.79 | 2023-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $213.69 | 2020-2025 | Cuvitru, Eohilia |
| Grifols USA, LLC | $172.09 | 2022-2025 | Xembify |
| Jazz Pharmaceuticals INC. | $162.44 | 2019-2025 | |
| Amgen INC. | $151.88 | 2022-2025 | Tezspire |
| Axsome Therapeutics, INC. | $148.92 | 2023-2025 | Sunosi |
| Pfizer INC. | $146.87 | 2020-2025 | |
| Kaleo, INC. | $137.64 | 2019-2024 | Auvi-Q |
| Harmony Biosciences LLC | $137.33 | 2020-2024 | Wakix |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $110.44 | 2023-2025 | Hizentra |
| Integra Lifesciences Corporation | $97.42 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Astrazeneca Pharmaceuticals LP | $92.46 | 2022-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $85.08 | 2019-2025 | |
| Zoll Respicardia, INC. | $68.90 | 2024 | Remede System |
| Medtronic, INC. | $62.21 | 2023-2024 | Propel |
| Hikma Pharmaceuticals USA | $60.59 | 2023-2024 | Ryaltris |
| Merck Sharp & Dohme LLC | $52.57 | 2023 | |
| Sanofi-Aventis U.S. LLC | $43.10 | 2019-2021 | |
| Acclarent, INC | $38.53 | 2019 | |
| Incyte Corporation | $36.97 | 2023-2025 | Opzelura |
| Alk-Abello, INC | $36.74 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $36.23 | 2025 | Xhance |
| Eyevance Pharmaceuticals LLC | $28.03 | 2020-2021 | |
| Lilly USA, LLC | $22.20 | 2025 | Zepbound |
| Aerin Medical INC. | $22.16 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $19.41 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $18.92 | 2025 | Neffy |
| Aytu Biopharma, INC. | $15.15 | 2023 | Karbinal |
| Shire North American Group INC | $14.43 | 2019 | |
| Circassia INC. | $13.08 | 2019 | |
| Intersect Ent, INC. | $12.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Acker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.